Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126930391 | 12693039 | 1 | I | 20070818 | 20151204 | 20160829 | 20160829 | EXP | GB-ROCHE-1821679 | ROCHE | 75.00 | YR | F | Y | 0.00000 | 20160829 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126930391 | 12693039 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
126930391 | 12693039 | 2 | SS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
126930391 | 12693039 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
126930391 | 12693039 | 4 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
126930391 | 12693039 | 5 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
126930391 | 12693039 | 6 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
126930391 | 12693039 | 7 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126930391 | 12693039 | 1 | Pancreatic carcinoma |
126930391 | 12693039 | 2 | Pancreatic carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126930391 | 12693039 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126930391 | 12693039 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |